Ttopstart has compiled a guide to funding possibilities for biotech and medtech companies in times of Corona crisis.
The Corona outbreak is a healthcare, societal and economic crisis with two faces for medtech and biotech: we are expected to come with solutions at unprecedented rates while ongoing developments are hit hard. Click the button below to find the guide on funding possibilities for both Corona R&D as well as non-corona R&D and support measures.